SERUM SOLUBLE INTERLEUKIN-2 RECEPTOR IS ASSOCIATED WITH CLINICAL AND PATHOLOGICAL DISEASE STATUS IN HAIRY-CELL LEUKEMIA
Authors:
- R MICKRMR MICK
- JM LATTAJLJM LATTA
- K DALYKDK DALY
- MJ RATAINMRMJ RATAIN
- JW VARDIMANJVJW VARDIMAN
- HM GOLOMBHGHM GOLOMB
- 15 November 1990
- journal article
- research article
- Vol. 76 (10) , 1941-1945
Abstract
Hairy cell leukemia is a chronic lymphoproliferative disorder of B-cell lineage, whose malignant cells express the interleukin-2 (IL-2) receptor. A soluble form and the IL-2 receptor is released by these cells in culture, and the sera of patients with hairy cell leukemia contain elevated levels of this soluble receptor. Four hundred twenty-seven serum samples from 101 patients were analyzed for soluble IL-2 receptor (sIL-2R). The clinical status of patients appeared to be associated with the serum level of sIL-2R. The hairy cell index (a measure of tumor cell burden) was correlated with the square root of the serum sIL-2R level (r = .77). Improved clinical status was associated with decreasing serum sIL-2R levels, whereas disease relapse was associated with increasing levels. Notably, every patient who responded to therapy had a decline in serum sIL-2R level, and every patient with disease progression had an increase in serum sIL-2R level. This phenomenon was observed for several different treatments, including standard-dose interferon, low-dose interferon, and deoxycoformycin. The predictive reliability of this test is currently being prospectively evaluated.Keywords
This publication has 12 references indexed in Scilit:
- Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables.Journal of Clinical Oncology, 1988
- SERUM SOLUBLE IL-2 RECEPTOR AS A TUMOR-MARKER IN PATIENTS WITH HAIRY-CELL LEUKEMIA1988
- SOLUBLE INTERLEUKIN-2 RECEPTORS IN THE SERA OF PATIENTS WITH HAIRY-CELL LEUKEMIA - RELATIONSHIP WITH THE EFFECT OF RECOMBINANT ALPHA-INTERFERON THERAPY ON CLINICAL-PARAMETERS AND NATURAL-KILLER INVITRO ACTIVITY1987
- Remissions in Hairy-Cell Leukemia with Pentostatin (2′-Deoxycoformycin)New England Journal of Medicine, 1987
- LOW-DOSE DEOXYCOFORMYCIN IN THE TREATMENT OF HAIRY-CELL LEUKEMIA1986
- Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.The Journal of Immunology, 1985
- TREATMENT OF HAIRY-CELL LEUKEMIA WITH RECOMBINANT ALPHA-2 INTERFERON1985
- Alpha Interferon for Induction of Remission in Hairy-Cell LeukemiaNew England Journal of Medicine, 1984
- Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.Proceedings of the National Academy of Sciences, 1983
- Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvementBlood, 1983